Oral contraceptives and reproductive system cancer

Annals of the New York Academy of Sciences

Volumn 997, Issue , 2003, Pages 199-208

  Deligeoroglou, E ^a,b   Michailidis, E ^a   Creatsas, G ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

Breast cancer; Cervical cancer; Combined oral contraceptives (COCs); Endometrial cancer; Ovarian cancer

Indexed keywords

HORMONE; ORAL CONTRACEPTIVE AGENT;

BREAST CANCER; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ENDOMETRIUM CANCER; ESTROGEN THERAPY; FEMALE GENITAL TRACT CANCER; HIGH RISK POPULATION; HUMAN; LONG TERM CARE; META ANALYSIS; OVARY CANCER; RISK FACTOR; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS; ADULT; AGE DISTRIBUTION; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; CONTRACEPTION; ENDOMETRIUM TUMOR; FEMALE; FOLLOW UP; GREECE; INCIDENCE; METHODOLOGY; MIDDLE AGED; OVARY TUMOR; REVIEW; RISK ASSESSMENT; UTERINE CERVIX TUMOR;

HUMAN PAPILLOMAVIRUS TYPES;

ADULT; AGE DISTRIBUTION; BREAST NEOPLASMS; CONTRACEPTION; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, HORMONAL; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GREECE; HUMANS; INCIDENCE; MIDDLE AGED; OVARIAN NEOPLASMS; RISK ASSESSMENT; UTERINE CERVICAL NEOPLASMS;

EID: 0642272531     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1290.023     Document Type: Conference Paper

References (32)

1. HANNAFORD, P. 2000. Health Consequences of Combined Oral Contraceptives. Br. Med. Bull. 56: 749-760.
2. VECCHIA, C., A. TAVANI, S. FRANCESCHI & F. PARAZZINI. 1996. Oral contraceptives and cancer. A review of the evidence. Drug Safety 14: 260-272.
3. EDELMAN, D.A. & W.A.A. VAN OS. 1997. Combined oral contraceptives and the risk of cervical cancer. Int. J. Gynaecol. Obstet. 56: 57-58.
4. SCHLESSELMAN, J. 1995. Net effect of oral contraceptive use on the risk of cancer in women in the United States. Obstet. Gynecol. 85: 793-801.
5. STERGACHIS, A. 1992. Epidemiology of the noncontraceptive effects of oral contracep-tives. Am. J. Obstet. Gynecol. 167: 1165-1169.
6. BERAL, V., P. HANNAFORD & C. KAY. 1988. Oral contraceptive use and malignancies of the genital tract. Results from the Royal College of General Practitioners' Oral Contraceptive Study. Lancet 2: 1331-1335.
7. SALAZAR, E.L., I. SOJO-ARANDA, R. LOPEZ & M. SALCEDO. 2001. The evidence for an etiological relationship between oral contraceptives use and dysplastic change in cervical tissue. Gynecol. Endocrinol. 15: 23-28.
8. BAIRD, D.T. & A.F. GLASIER. 1993. Hormonal contraception. N. Engl. J. Med. 328: 1543-1547.
9. THE WHO COLLABORATIVE STUDY OF NEOPLASIA AND STEROID CONTRACEPTIVES. 1988. Endometrial cancer and combined oral contraceptives. Int. J. Epidemiol. 17: 263-269.
10. JICK, S., A. WALKER & H. JICK. 1993. Oral contraceptives and endometrial cancer. Obstet. Gynecol. 82: 931-935.
11. SCHLESSELMAN, J. 1997. Risk of endometrial cancer in relation to use of combined oral contraceptives. A practitioner's guide to meta-analysis. Hum. Reprod. 12: 1851-1863.
12. STANFORD, J., L. BRINTON, M. BERMAN, et al. 1993. Oral contraceptives and endometrial cancer: Do other risk factors modify the association? Int. J. Cancer 54: 243-248.
13. WEIDERPASS, E., H.O. ADAMI, J. BARON, et al. 1999. Use of oral contraceptives and endometrial cancer risk (Sweden). Cancer Causes Control 10: 277-284.
14. NESS, R., J.A. GRISSO, R. VERGONA, et al. 2001. Oral contraceptives, other methods of contraception and risk reduction for ovarian cancer. Epidemiology 12: 307-312.
15. THE CANCER AND STEROID HORMONE STUDY OF THE CENTERS FOR DISEASE CONTROL AND THE NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT. The reduction in risk of ovarian cancer associated with oral-contraceptive use. N. Engl. J. Med. 316: 650-655.
16. VESSEY, M.P. & R. PAINTER. 1995. Endometrial and ovarian cancer and oral contraceptives-findings in a large cohort study. Br. J. Cancer 71: 1340-1342.
17. SISKID, V., A. GREEN, C. BAIN & D. PURDIE. 2000. Beyond ovulation: oral contraceptives and epithelial ovarian cancer. Epidemiology 11: 106-110.
18. NESS, R., J.A. GRISSO, J. KLAPPER, et al. 2000. Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptive Am. J. Epidemiol. 152: 233-241.
19. SANDERSON, M., M. WILLIAMS, N. WEISS, et al. 2000. Oral contraceptives and epithelial ovarian cancer: Does dose matter? J. Reprod. Med. 45: 720-726.
20. GROSS, T.P. & J. SCHLESSEMAN. 1994. The estimated effect of oral contraceptive use on the cumulative risk of epithelial ovarian cancer. Obstet. Gynecol. 83: 419-424.
21. GODARD, B., W.D. FOULKES, D. PROVENCHER, et al. 1998. Risk factors for familial and sporadic ovarian cancer among French Canadians: a case control study. Am. J. Obstet. Gynecol. 179: 403-410.
22. NAROD, S.A., H. RISCH, R. MOSHELI, et al. 1998. Oral contraceptive and the risk of hereditary ovarian cancer. N. Engl. J. Med. 339: 424-428.
23. WALKER, G., J. SCHLESSEMAN & R. NESS. 2002. Family history of cancer, oral contraceptive use, and ovarian canver risk. Am. J. Obstet. Gynecol. 186: 8-14.
24. SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS PROGRAM. 1988. Annual cancer statistics review including cancer trends 1950-1985. National Institutes of Health. Bethesda, MD.
25. CANCER AND STEROID HORMONE STUDY OF THE CENTERS FOR DISEASE CONTROL AND THE NATIONAL INSTITUTE OF THE CHILD HEALTH AND HUMAN DEVELOPMENT. 1986. Oral contraceptive use and the risk of breast cancer. N. Engl. J. Med. 315: 405-411.
26. ROMIEU, I., W.C. WILLET, G. A. COLDITZ, et al. 1989. Prospective study of oral contraceptive use and risk of breast cancer in women J. Natl. Cancer Inst. 81: 1313-1321.
27. UK NATIONAL CASE-CONTROL STUDY GROUP. 1990. Oral contraceptive use and breast cancer in young women: subgroup analyses. Lancet 335: 1507-1509.
28. ROOKUS, M. & F. VAN LEEUWEN. 1994. Oral contraceptives and risk of breast cancer in women aged 20-54 years. Lancet 344: 844-851.
29. URSIN, G., R. ROSS, J. SULLIVAN-HALLEY, et al. 1998. Use of oral contraceptives and risk of breast cancer in young women. Breast Cancer Res. Treat. 50: 175-184.
30. TOMASSON, H. & K. TOMASSON. 1996. Oral contraceptives and risk of breast cancer: A historical prospective case-control study. Acta Obstet. Gynecol. Scand. 75: 157-161.
31. COLLABORATIVE GROUP ON HORMONAL FACTORS IN BREAST CANCER 1996. Breast cancer and hormonal contraceptives: collaborative reanalysis of Individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet. 347: 1713-1727.
32. MARCHBANKS, P., J. MCDONALD, H. WILSON, et al. 2002. Oral contraceptives and the risk of breast cancer. N. Engl. J. Med. 346: 2025-2032.